Faculty profile

Rachel Glicksman

Back to faculty

Assistant ProfessorDepartment of Radiation OncologyUniversity of Toronto

Rachel Glicksman

Assistant Professor

Department of Radiation Oncology

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
12 publications in the last five years, latest in 2026.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

501

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

Health-Related Quality of Life After SBRT for Oligoprogressive Disease: Results From a Phase II Prospective Trial.
International journal of radiation oncology, biology, physics · 2026
Initial Experience with MR-Guided or CT-Guided Stereotactic Body Radiotherapy for Prostate Cancer.
Current oncology (Toronto, Ont.) · 2026
Primary Retroperitoneal Lymph Node Dissection in Marker-Positive Clinical Stage II Nonseminomatous Germ Cell Tumors.
The Journal of urology · 2026

All 23 publications

Latest funding

Androgen Suppression Combined with Elective Nodal and a Dose Escalated Boost. A Non-Inferiority, Phase 3 Randomized Controlled Trial of Stereotactic Body Radiation Therapy versus Brachytherapy Boost (ASCENDE-SBRT)
CIHR · 2022 · Co-investigator
$4,475,254

All 1 grants and awards

23 publications.

Health-Related Quality of Life After SBRT for Oligoprogressive Disease: Results From a Phase II Prospective Trial.

Helou J, Glicksman R, Bezjak A, Raman S, Chen E, Chung P, Dawson LA, Hope A, Hosni A, Javor J, Lindsay P, Yan M, Wong R, Ye XY, Barry A

International journal of radiation oncology, biology, physics20261 citations

DOI: 10.1016/j.ijrobp.2025.12.070 PMID: 41547376

Initial Experience with MR-Guided or CT-Guided Stereotactic Body Radiotherapy for Prostate Cancer.

Barcelona MVN, Sanmamed Salgado N, Valencia EG, Berlin A, Glicksman R, Catton C, McPartlin A, Winter JD, Dang J, Kong V, Deng Y, Chung P

Current oncology (Toronto, Ont.)2026Open Access

DOI: 10.3390/curroncol33090504 PMID: 42782851

Primary Retroperitoneal Lymph Node Dissection in Marker-Positive Clinical Stage II Nonseminomatous Germ Cell Tumors.

Mousa A, Chavarriaga J, Kaushal S, Burrafato Z, Anson-Cartwright L, Atenafu EG, Bedard P, Jiang DM, Glicksman R, Chung P, Warde P, O'Malley M, Prendeville S, Jewett MAS, Hamilton RJ

The Journal of urology2026

DOI: 10.1097/ju.0000000000004847 PMID: 41212998

Postchemotherapy orchiectomy in metastatic testicular germ cell tumors: Pathologic findings and predictors of residual viable disease.

Mousa A, Hayes J, Amiri A, Anson-Cartwright L, Atenafu EG, Bedard P, Jiang DM, Glicksman R, Chung P, Warde P, O'Malley M, Prendeville S, Hamilton RJ

Urologic oncology2026

DOI: 10.1016/j.urolonc.2026.111082 PMID: 41934019

Peripheral monocyte ratio as a predictive biomarker for metastasis-directed therapy in prostate cancer: insights from an exploratory study.

Wang H, Rajagopal A, Cao K, Cimolai K, Petchiny TN, White SD, Cheung J, Loblaw A, Vesprini D, Leong H, Escueta V, Zhang L, Glicksman R, Cheung P, Wang C, Liu SK

BMC cancer2026Open Access

DOI: 10.1186/s12885-026-15854-1 PMID: 41888707

Clinical Outcomes and Institutional Experience of Ultrahypofractionated Radiation Therapy in Patients With Breast Cancer.

Othman H, Barry A, Fyles A, Rodin D, Hahn E, Liu FF, Helou J, Han K, Glicksman R, Isfahanian N, Baskurt Z, Chan M, Purdie T, Koch A, Croke J

Advances in radiation oncology2026Open Access

DOI: 10.1016/j.adro.2025.101948 PMID: 41541755

Partial or focal brachytherapy for prostate cancer: a systematic review and meta-analysis.

Gutiérrez-Valencia E, Navarro-Domenech I, Zhou K, Barcelona M, Fazelzad R, Ramotar M, Sanchez I, Ruiz V, Weersink R, Glicksman R, Helou J, Berlin A, Chung P, Chow R, Raman S

The British journal of radiology20257 citationsOpen Access

DOI: 10.1093/bjr/tqae254 PMID: 39700435

Dose-response of localized renal cell carcinoma after stereotactic body radiation therapy: A meta-analysis

Ryan S. Huang, Ronald Chow, Pradnya Chopade, Andrew Mihalache, Asad Shahzad Hasan, Gabriel Boldt, Rachel Glicksman, Charles B. Simone, Michael I. Lock, Srinivas Raman

Radiotherapy and Oncology202414 citationsOpen Access

DOI: 10.1016/j.radonc.2024.110216 PMID: 38462092

Primary retroperitoneal lymph node dissection for metastatic non-seminomatous germ cell tumours: outcomes and adjuvant chemotherapy.

Mousa A, Anson-Cartwright L, Atenafu EG, Jewett MAS, Bedard P, Jiang DM, Glicksman R, Chung P, Warde P, O'Malley M, Prendeville S, Hamilton RJ

BJU international20247 citationsOpen Access

DOI: 10.1111/bju.16448 PMID: 38967557

TOward a comPrehensive supportive Care intervention for Older men with metastatic Prostate cancer (TOPCOP3): A pilot randomized controlled trial and process evaluation.

Alibhai SMH, Puts M, Jin R, Godhwani K, Antonio M, Abdallah S, Feng G, Krzyzanowska MK, Soto-Perez-de-Celis E, Papadopoulos E, Mach C, Nasiri F, Sridhar SS, Glicksman R, Moody L, Bender J, Clarke H, Matthew A, McIntosh D, Klass W, Emmenegger U

Journal of geriatric oncology20246 citationsOpen Access

DOI: 10.1016/j.jgo.2024.101750 PMID: 38521641

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Rachel Glicksman

Research

Latest papers

Latest funding

Health-Related Quality of Life After SBRT for Oligoprogressive Disease: Results From a Phase II Prospective Trial.

Initial Experience with MR-Guided or CT-Guided Stereotactic Body Radiotherapy for Prostate Cancer.

Primary Retroperitoneal Lymph Node Dissection in Marker-Positive Clinical Stage II Nonseminomatous Germ Cell Tumors.

Postchemotherapy orchiectomy in metastatic testicular germ cell tumors: Pathologic findings and predictors of residual viable disease.

Peripheral monocyte ratio as a predictive biomarker for metastasis-directed therapy in prostate cancer: insights from an exploratory study.

Clinical Outcomes and Institutional Experience of Ultrahypofractionated Radiation Therapy in Patients With Breast Cancer.

Partial or focal brachytherapy for prostate cancer: a systematic review and meta-analysis.

Dose-response of localized renal cell carcinoma after stereotactic body radiation therapy: A meta-analysis

Primary retroperitoneal lymph node dissection for metastatic non-seminomatous germ cell tumours: outcomes and adjuvant chemotherapy.

TOward a comPrehensive supportive Care intervention for Older men with metastatic Prostate cancer (TOPCOP3): A pilot randomized controlled trial and process evaluation.

Androgen Suppression Combined with Elective Nodal and a Dose Escalated Boost. A Non-Inferiority, Phase 3 Randomized Controlled Trial of Stereotactic Body Radiation Therapy versus Brachytherapy Boost (ASCENDE-SBRT)

Frequent collaborators

Peter Chung

Alejandro Berlin

Padraig Warde

Neil Fleshner

Martin O'Malley

Philippe Bedard

Charles Catton

Susan Prendeville

Antonio Finelli

Michael Milosevic

Andrew McPartlin

Ali Hosni

Vickie Kong

Andrew Bayley

Anthony Fyles

Kathy Han

Eric Leung

Winnie Li

Patricia Lindsay

Tara Rosewall

Anne Koch

Ezra Hahn

Rebecca Wong

Danny Vesprini

Lesley Moody

Monika Krzyzanowska

Paul Boutros

Stanley Liu

Nathan Perlis

Jacqueline Bender

Andrew Hope

Juanita Crook

Chao Wang